Recruiting studies: Psychedelic Experiences

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The ENHANCE Study: taVNS and Psilocybin
Phase 1 · 1 location(s) · University of Wisconsin, Madison · NCT05866471 Psilocybin With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring PTSD & Alcoh
Phase 2 · 1 location(s) · Nathan Brashares Sackett · NCT06853912 Psilocybin Administration With 5-HT1a Blockade
EARLY_Phase 1 · 1 location(s) · Johns Hopkins University · NCT07565493 Subjective Experience Following Psilocybin
Phase 2 · 1 location(s) · University of Calgary · NCT06768944 Antidepressant Response of DMT Masked With Propofol
NA · 1 location(s) · University Hospital, Basel, Switzerland · NCT06927076 Elucidating the Relevance of the Psychedelic Experience to Psilocybin's Anti-Anhedonic Effects
Phase 1 · 1 location(s) · Medical University of Vienna · NCT07490353 Safety for Home Administration of Microdose Psilocybin Use
Phase 1 · 1 location(s) · Johns Hopkins University · NCT06450210

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.